Overall rank by patents
#40,001
of 49,997 tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, recorded in grant years 2020–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).
The verdict
According to USPTO PatentsView, Ellume ranks #40,001 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 3 technology areas.
USPTO PatentsView assignee plate
Corpus R40001 · Foreign Corporation #40,001 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Elid Technology International Pte Ltd (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Ellume · this assignee
26 score
3D Lighting… · lowest
7 score
What this shows Ellume's Innovation Score is 26.0/100 (19th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Ellume Limited is a focused PatentsView assignee: 3 CPC subclasses with 66.7% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2021. By volume, Ellume sits between Elid Technology International Pte Ltd and Emergo Therapeutics, Inc..
Ellume Limited shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Elid Technology International Pte Ltd
6 patents
Elixiron Immunotherapeutics (Hong Kong) Limited
6 patents
Elka International Ltd.
6 patents
Elkins Earthworks, LLC
6 patents
Elsevier B.V.
6 patents
Elum Inc.
6 patents
Emanate Biomedical, Inc.
6 patents
Emergo Therapeutics, Inc.
6 patents
Ellume Limited
6 patents
What this shows Ellume holds 6 patents at rank #40,059, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #40,059 in granted patent volume.
Other assignees with the most granted patents in Ellume's primary technology class.
Ellume's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
26 19th percentile higher than 19% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 3 | 50.0% |
| 2021 | 1 | 16.7% |
| 2022 | 2 | 33.3% |
Top 3 of 3 technology areas
Overall rank by patents
#40,001
of 49,997 tracked assignees
26.0 out of 100
What to do with this data
Ellume Limited's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.